Triple-hit Lymphoma (THL) (DBCOND0118158)

Identifiers

Synonyms

Triple hit lymphoma

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05908409	A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies	No drug interventions	treatment	1 / 2	recruiting
NCT05974085	XPO-1 in Combination With RCHOP for DH/TH Lymphoma	Selinexor	treatment	2	recruiting
NCT01742988	Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma	Fimepinostat Rituximab Venetoclax	treatment	1	completed